Document is current
Any future updates will be listed below
-
Authors
Bientz, Léa
Boijout, Hugo
Grami, Raoudha
Guyet, Ulysse
Lahouati, Marin
Hertzmann, Melissande
Marques, Antony
Toirot, Audrey
Aillerie, Sabine
Coulange-Mayonnove, Laure
Groppi, Alexis
Nikolski, Macha
Bébéar, Cécile
Dubois, Véronique
-
Funding
Funding for this research was provided by:
Joint Programming Initiative on Antimicrobial Resistance (MAGITICS_JPIAMR_2019_P011)
Joint Programming Initiative on Antimicrobial Resistance (MAGITICS_JPIAMR_2019_P011)
- License Information
-
More Information
Article History
Received: 13 March 2025
Accepted: 29 October 2025
First Online: 9 December 2025
Declarations
:
: Our study followed the MR-004 reference methodology, which governs the processing of retrospective and prospective personal data for health studies and evaluations in France. It was approved by the Data Protection Officer, and patients were informed about data collection in compliance with the EU General Data Protection Regulation. According to MR-004 and French legislation, written patient consent is no longer required before using their data. Patients did not oppose the use of their data for research purposes. Ethics approval is unnecessary according to national French regulations, MR-004 ( ).
: Not applicable.
: The authors declare no competing interests.
